Comparison of four commercial urinary albumin (microalbumin) methods: Implications for detecting diabetic nephropathy using random urine specimens

Clinica Chimica Acta

Volumn 273, Issue 1, 1998, Pages 21-33

  Roberts, William L ^a   Calcote, Clay B ^a   Cook, Curtiss B ^a   Gordon, Douglas L ^b   Moore, Marcia L ^a   Moore, Spring ^c   Scheer, W Douglas ^c   Snazelle, Beatrice A ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Diabet Ctr of the Baton Rouge G   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Albumin creatinine ratio; Analytical methods; Diabetic nephropathy; Method bias; Microalbumin; Urinary albumin

Indexed keywords

ALBUMIN;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC NEUROPATHY; EXCRETION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; URINALYSIS;

ALBUMINURIA; CREATININE; DIABETIC NEPHROPATHIES; HUMANS; NEPHELOMETRY AND TURBIDIMETRY; REFERENCE VALUES;

EID: 0032496423     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00021-7     Document Type: Article

References (11)

1. [1] Bennett PH, Haffner S, Kasiske BL et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995;25:107-12.
2. [2] Nelson RG, Knowler WC, Pettitt DJ, Saad MF, Charles MA, Bennett PH. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med 1991;151:1761-5.
3. [3] Crofford OB. Diabetes control and complications. Annu Rev Med 1995;46:267-79.
4. [4] Brancati FL, Cusumano AM. Epidemiology and prevention of diabetic nephropathy. Curr Opin Nephrol Hypertens 1995;4:223-9.
5. [5] Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-81.
6. [6] Sano T, Hotta N, Kawamura T et al. Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study. Diabetic Med 1996;13:120-4.
7. [7] Bakris GL, Williams B. Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ? J Hypertens 1995;13:S95-101.
8. [8] Tiu SC, Lee SS, Cheng MW. Comparison of six commercial techniques in the measurement of microalbuminuria in diabetic patients. Diabetes Care 1993;16:616-20.
9. [9] Giampietro O, Penno G, Clerico A et al. Which method for quantifying "microalbuminuria" in diabetics? Comparison of several immunological methods (immunoturbidimetric assay, immunonephelometric assay, radioimmunoassay and two semiquantitative tests) for measurement of albumin in urine. Acta Diabetol 1992;28:239-45.
10. [10] Cembrowski GS. Testing for microalbuminuria: promises and pitfalls. Lab Med 1990;21:491-6.
11. [11] Thakkar H, Newman DJ, Holownia P et al. Development and validation of a particle-enhanced turbidimetric inhibition assay for urine albumin on the Dade aca® analyzer. Clin Chem 1997;43:109-13.